How to Screen for Hereditary Cancers in General Pathology Practice

Area of Science:

• Pathology
• Genetics
• Oncology

Background:

• Pathologists can identify genetic syndromes through sentinel diagnoses.
• Keeping up with evolving diagnostic and treatment options is challenging.
• Immunohistochemistry is a useful tool in hereditary cancer screening, particularly for Lynch syndrome.

Purpose of the Study:

• To highlight the utility of hematoxylin-eosin (H&E) morphology in hereditary cancer screening.
• To emphasize H&E morphology as a valuable diagnostic tool alongside newer techniques.

Main Methods:

• Primary literature review using PubMed.

Main Results:

• Recognition of specific tumor morphologies associated with hereditary cancer predisposition.
• Identification of individuals and families at high risk for hereditary cancers.

Conclusions:

• H&E morphology aids in identifying high-risk individuals and families for genetic syndromes.
• Diagnostic findings have implications for targeted therapy and primary prevention strategies.